Shareholder Class Action

Noven Pharmaceuticals is selling itself too cheaply to Hisamitsu Pharmaceutical, for $16.50 a share or $428 million, shareholders say in Delaware Chancery Court.           Directors of Citigroup mismanaged the company wasted corporate assets and concealed it since 2005, shareholders say in New York County Court.           Comtech Communications inflated its share price through false and misleading statements, shareholders claim in Central Islip, N.Y., Federal Court.           Integral Systems issued false and misleading financial reports, shareholders say in Greenbelt, Md., Federal Court.